Status:

UNKNOWN

Capsaicin for Post-stroke Dysphagia

Lead Sponsor:

Georg Kägi, MD

Collaborating Sponsors:

Cantonal Hospital of Aarau, Switzerland

University Hospital, Basel, Switzerland

Conditions:

Dysphagia, Late Effect of Stroke

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Randomised, double blind, Phase 2 Trial to evaluate the efficacy of oral Capsaicin in patients with post-stroke dysphagia in the (sub-)acute setting.

Detailed Description

After inclusion and the assessment of the swallowing function (PRESS, PAS, FOIS, FEES) patients will be randomised 1:1 to receive 1mcg Capsaicin or Placebo. Oral treatment will be applied 3 times dail...

Eligibility Criteria

Inclusion

  • Acute ischemic Stroke
  • Impairment of oral intake with FOIS ≤ 4
  • Magnetic Resonance Imaging of the brain or CT scan with the finding of a subacute ischemic stroke
  • Informed Consent within 48 hours after admission, following initial swallowing assessment

Exclusion

  • Diagnosis other than ischemic stroke
  • Late patient admission \>48 hours after stroke onset
  • Impairment of functional oral intake scale ≥ 5
  • FEES \>72h after admission
  • PAS \<2
  • Pre-existing dysphagia
  • Dysphagia due to other cause
  • No evidence of stroke on imaging
  • Recurrent stroke = at least one stroke in the course of the study apart from the index stroke
  • Age \<18 years
  • Current drug abuse
  • Amphetamine or amphetamine-like Medication
  • Regular oral treatment with chilli pepper extract
  • Allergies or known adverse reactions to the consumption of chilli pepper or capsaicin
  • Personality disorder
  • Severe dementia or delirium
  • Other reasons according to physician/investigator because of which the patient cannot participate in the study (not suitable for treatment or examinations)
  • withdrawal of consent by participant at any time of the study

Key Trial Info

Start Date :

August 24 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2024

Estimated Enrollment :

82 Patients enrolled

Trial Details

Trial ID

NCT04470752

Start Date

August 24 2021

End Date

December 1 2024

Last Update

June 22 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Kantonsspital St. Gallen

Sankt Gallen, Canton of St. Gallen, Switzerland, 9007